Skip to content

Effect of narrow band UVB with needling versus narrow band UVB alone on the treatment of vitiligo

Effect of narrow band UVB with needling versus narrow band UVB alone on the treatment of vitiligo: a single blinded randomized clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201402169014N24
Enrollment
29
Registered
2014-02-22
Start date
2012-07-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. Vitiligo

Interventions

Intervention 1: Needling the margin of the vitiligo lesion toward the center once a week before phototherapy for three months plus phototherapy with NB-UVB once a week for three months. Intervention 2
Treatment - Drugs
Placebo
Needling the margin of the vitiligo lesion toward the center once a week before phototherapy for three months plus phototherapy with NB-UVB once a week for three months
Phototherapy with NB-UVB alone once a week for three months

Sponsors

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (a) age of older than of years; (b) having bilateral symmetrical vitiligo lesions on upper or lower limbs, face, or trunk; (c) the vitiligo is either stable or progressive; (d) at least 10% of the body surface is affected by the disease. Exclusion criteria: (a) being immunodeficient; (b) being spontaneous repigmentation; (c) having any contraindications for phototherapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Repigmentation of the lesion. Timepoint: in the sixth and twelfth weeks. Method of measurement: based on VASI criteria.

Secondary

MeasureTime frame
Evaluation of probable superficial burn. Timepoint: weekly before phototherapy. Method of measurement: through clinical observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mayam Rasouli Mohit

Farshchian Hospital,

rasouli27@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026